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Physical inactivity is increasingly recognized as modiﬁable behavioral risk factor for cardiovascular diseases. A partial list
of proposed mechanisms for exercise-induced cardioprotection include induction of heat shock proteins, increase in cardiac
antioxidant capacity, expression of endoplasmic reticulum stress proteins, anatomical and physiological changes in the coronary
arteries, changes in nitric oxide production, adaptational changes in cardiac mitochondria, increased autophagy, and improved
function of sarcolemmaland/or mitochondrial ATP-sensitive potassium channels. It is currently unclear which of these protective
mechanisms are essential for exercise-induced cardioprotection. However, most investigations focus on sarcolemmal KATP
channels, NO production, and mitochondrial changes although it is very likely that other mechanisms may also exist. This paper
discusses current information about these aforementioned topics and does not consider potentially important adaptations within
blood or the autonomic nervous system. A better understanding of the molecular basis of exercise-induced cardioprotection will
help to develop better therapeutic strategies.
1.Introduction
It is generally accepted that regular exercise is an eﬀective
way for reducing cardiovascular morbidity and mortality
[1]. Physical inactivity and obesity are also increasingly
recognized as modiﬁable behavioral risk factors for a wide
range of chronic diseases, including cardiovascular diseases.
Furthermore, epidemiologic investigations indicate that the
survival rate of heart attack victims is greater in physically
active persons compared to sedentary counterparts [2].
Several large cohort studies have attempted to quantify the
protective eﬀect of physical activity on cardiovascular and
all cause mortality. Nocon et al. [3]i nam e t a - a n a l y s i so f
33 studies with 883,372 participants reported signiﬁcant risk
reductions for physically active participants. All-cause mor-
tality was reduced by 33%, and cardiovascular mortality was
associated with a 35% risk reduction. Exercise capacity or
cardiorespiratory ﬁtness is inversely related to cardiovascular
and all-cause mortality, even after adjustments for other
confounding factors [4–6].
The American College of Sports Medicine deﬁnes exer-
cise as “Any and all activity involving generation of force by the
activated muscle(s) that results in disruption of a homeostatic
state”. Exercise is classiﬁed by the type, intensity, and dura-
tion of activity. Endurance exercise reﬂects prolonged and
continuous periods of contractile activity (high repetition)
against low resistance whereas resistance exercise (strength
training) involves short periods of contractile activity (low
repetition) against a high opposing resistance, while sprint
exercise occurs during short periods of maximal (intense)
repetitive contractile activity, where there is a short period
of exercise against a low resistance, such as running a 100-m
sprint race. However, sprint training can also be performed
against high resistance, which results in a combination of
resistance and endurance modalities, for example, running
with added weights [7].
Although it is clear that exercise promotes a cardiopro-
tective phenotype, a detailed understanding of the cellular
mechanisms responsible for this cardioprotection remains
incomplete. The cytoprotective mechanisms that have gar-
nered most attention are inducible heat shock proteins and
antioxidantenzymes, especiallysuperoxidedismutase(SOD)
[8–11]. However, there are numerous clues suggesting that
other mechanisms may also be part of exercise-induced2 Cardiology Research and Practice
cardioprotective phenotype, and they may have signiﬁcant
roles inthe protectiveprocess. Improving our understanding
of the molecular basis for exercise-induced cardioprotection
will play an important role in developing optimal exercise
interventions for primary and secondary prophylaxis. The
objective of this paper is to summarize the body of knowl-
edge related to the molecular basis of cardioprotective eﬀects
of exercise and the evidence for other potential mediators.
We mainly focused on adaptations within the cardiac mus-
cles and will brieﬂy examine coronary adaptations as well.
However, it should be noted that other adaptive mechanisms
in the blood, humoral and autonomic nervous system,
muscles, and so forth can also aﬀect this process.
2.Exercise-InducedExpressionof
HSPsinthe Heart
The ability of organisms to respond to various stressors
was ﬁrst described by Selye in 1936, who suggested a series
of programmed events that help organisms to cope with
the situation [12]. The heat shock response is a common
cellular reaction to external stimuli such as ischemia [13],
hypoxia [14], acidosis [15], oxidative stress [16], protein
degradation [17], increased intracellular calcium [18], and
energy depletion [19]( Table 1). Therefore, the terms “stress
proteins” and “cellular stress response” reﬂect the array
of stressors known to initiate heat shock protein (HSP)
expression[20].Itisgenerallyacceptedthatexerciseincreases
the expression of cardiac HSPs. Locke et al. [21] performed
a comprehensive study of the eﬀe c t so fa c u t ee x e r c i s eo n
myocardial expression of HSPs and showed that the expres-
sion of HSPs can begin within 30–60min after an exercise
bout in the rat myocardium. The mechanistic link between
exercise and myocardial expression of HSPs is unclear. How-
ever, a variety of stresses associated with exercise, including
heat stress and hypoxia, reduced intracellular pH, reactive
oxygen and nitrogen species (ROS and RNS) production,
and depletion of glucose and glycogen stores, increase in
cytosolic calcium levels and cardiomyocyte stretching can all
contribute to HSP elevation in cardiac muscle [22]. Several
stress proteins such as HSP10, HSP40, HSP60, and HSP90
are thought to play cardioprotective roles [23, 24], with
some detailed understanding of the role of the HSP70 family
[25]. Production of HSP70 in the rat myocardium during
treadmillrunningismediatedbyanincreaseintheactivation
of heat shock transcription factor 1 (HSF 1), which then
binds to the heat shock element of HSP70 genes and results
in increased levels of HSP70 mRNA [26]. In an attempt
to provide additional insights, Melling et al. showed that
proteinkinase A(PKA),and notprotein kinase C,playsa key
roleinexercise-inducedregulationofHSP70geneexpression
[27]. Activation of PKA mediates the suppression of an
intermediary protein kinase, extracellular signal regulated
kinases (ERK1/2), which phosphorylates and suppresses
the activation of the HSF1. However, following exercise
training, ERK1/2 regulates the transcriptional activation of
several genes involved in cell growth and proliferation and
has been shown to be associated with training-mediated
myocardial hypertrophy. In another study, Melling et al.
[28] reported increased expression of HSP70 following a
single bout of exercise in the presence of elevated ERK1/2 in
trained animals. These results suggest that training results in
adaptationsthatallowforthesimultaneousinitiationofboth
proliferative and protective responses. In addition, HSP72 (a
member of HSP70 family) augments myocardial antioxidant
capacity [29]. During ischemia/reperfusion (I/R) insult,
HSP72 preserves mitochondrial function and provides cel-
lular protection against apoptosis [30, 31]. Moreover, by
prevention of protein aggregation and denaturation, HSP72
also enhances recovery from acute cellular injury and so
protects cells from subsequent injury [32].
Although exercise induces cardiac HSP72 expression
(which is cardioprotective), there are some reports demon-
strating that the beneﬁcial eﬀects of exercise on cardiac
muscle is independent of HSPs formation [33]. Hamilton
et al. postulated that exercise associated cardioprotection
may depend, in part, on increases in myocardial content
manganese superoxide dismutase (MnSOD), rather than
HSP levels [34], while studies by Quindry et al. sug-
gest that exercise-induced myocardial protection against
I/R is unrelated to increases in cardiac levels of HSP10,
HSP27, HSP40, HSP60, HSP72, HSP73, or HSP90 [35,
36]. One explanation for these ﬁndings is the activation
of cardioprotective mechanisms through diﬀerent pathways
that then converge on common distal pathways, suggesting




Cells have evolved highly complex antioxidant systems
(enzymic and nonenzymic), which work synergistically
to protect cells and organ systems of the body against
free radical-induced damage. The most eﬃcient enzymatic
antioxidants involve glutathione peroxidase, catalase, and
superoxide dismutase. Nonenzymatic antioxidants include
vitamins E and C and thiol antioxidants (glutathione,
thioredoxin) [38]. Each of these antioxidants is capable
of combining with reactive oxidants to produce other less
reactive spices. Superoxide dismutase promotes the dismu-
tation of the superoxide radicalt of o r mh y d r o g e np e r o x i d e
(H2O2) and oxygen. While glutathione peroxidase (GPx)
uses reduced glutathione (GSH), as a reducing equivalent,
to reduce H2O2 to form oxidized glutathione and water.
Furthermore, GSH can remove selected oxygen radicals
directly and assist in the recycling of vitamin C and E
(Table 2).
Catalase converts H2O2 to water and oxygen. The
newly identiﬁed peroxiredoxin family represents a group of
peroxidases that also catalyze the reduction of H2O2.T h e y
includeatleast six isoforms inmammalian cells[39]. Among
them, peroxiredoxin III is synthesized with a mitochondrial
targeting sequence, as is MnSOD.
The eﬀects ofexercise on myocardial antioxidant enzyme
activities has been widely investigated but with variable
conclusions. For example, while some studies report that
exercise-induced increases in GPx activity [40, 41], othersCardiology Research and Practice 3
Table 1: Cellular location and function of selected heat shock proteins (HSPs) [22, 23, 32, 37].
Family Members Cellular location Proposed function (comment)
Ubiquitin Ubiquitin Cytosol Protein degradation (ubiquitin levels in cells increase following
cellular injury)
HSP10 HSP10 Mitochondria Molecular chaperons, cofactor for HSP60
HSP27 HSP27, HSP26, and so
forth Cytosol, nucleus Microﬁlament stabilization,antiapoptotic (variable in size and
number in diﬀerent organisms)
HSP60 HSP60 Mitochondria Refolds proteins and prevents aggregation of denatured proteins,
proapoptotic.





Molecular chaperons, protein folding, and cytoprotection (HSP72
postulated to play an important role in myocardial protection
against I/R injury).
HSP90 HSP90, HSP100, Grp94 Cytosol, nucleus, ER
May function as a molecular chaperone during maturation of
steroid receptors and assists in the folding of newly synthesized
peptides, protein translocation.
suggestthatmyocardial GPx activity is notaltered byexercise
[42, 43]. Such equivocal results have also been reported for
myocardial catalase, with increased [44, 45]a n dd e c r e a s e d
[33, 43] levels. Although there is no clear explanation for
these discrepancies, it is possible that the use of exercise
protocols that diﬀer in duration and intensity may be
an important underlying factor. The strongest evidence
to directly link increases in myocardial antioxidants and
exercise-induced cardioprotection implicates a contributory
role for MnSOD. It is generally believedthat evenshort-term
endurance exercise results in a rapid increase in myocardial
MnSOD activity [43, 46, 47] as shown in studies that
employed antisense oligonucleotide techniques to silence
MnSOD genes and so prevent exercise-induced increases
in myocardial MnSOD activity [46, 48]. For example,
Yamashita et al. [46] reported that inhibition of exercise-
induced increases in cardiac MnSOD abolished protection
against myocardial infarction, ﬁndings that were conﬁrmed
by Hamilton et al. [49] who concluded that MnSOD plays a
keyroleagainstI/R-inducedcardiacarrhythmias. Incontrast,
Lennon et al. [50] reported that exercise-induced increases
in cardiac MnSOD activity is not essential to achieve
exercise-mediated protection against myocardial stunning. It
is possible that mechanisms responsible for exercise-induced





The induction of myocardial HSPs and upregulation of
cardiac antioxidant enzymes are well-studied aspects of the
response to exercise. Other related responses to exercise-
induced cardioprotection includeanatomical and physiolog-
ical changes in the coronary arteries, increased myocardial
cyclooxygenase-2 (COX-2) activity, elevated endoplasmic
reticulum stress proteins, nitric oxide production, increased
autophagy, and improved function of sarcolemmal and/or
mitochondrial ATP sensitive potassium (sarco KATP and/or






















Figure 1: Sequence of pathologic events in ischemia reperfusion
injury.
5.Myocardial CollateralCirculation
Exercise-induced adaptation of the coronary circulation
can be divided into two major processes: (a) angiogenesis,
which is an expansion of the capillary network by the
formation of new blood vessels and occurs at the level of
capillaries and resistance arterioles, but not in large arteries
and (b) arteriogenesis, which is as enlargement of existing
vessels [53].
5.1. Angiogenesis. It has been speculated that endurance
exercise stimulates angiogenesis by either a division of
preexisting endothelial cells or by bone marrow-derived
endothelial progenitor cells and monocyte or macrophage
derived angiogenic cells [54]. Some reports indicate that
physical activity improves the mobilization of endothelial
progenitor cells in healthy subjects and in patients with
cardiovascular risk and coronary artery disease [55, 56].
Indeed, angiogenesis is regulated by a net balance between
positive (angiogenic) and negative (angiostatic) regulators
of blood vessel growth. A balance favoring predominantly
positive regulators are an angiogenic phenotype whereas a
shiftfavoringnegativeregulatorsisanangiostaticphenotype.
Therefore, an impaired regulation of angiogenesis is often
associated with the development of angiogenesis-dependent
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Figure 2: Proposed mechanisms for exercised-induced cardioprotection.
Endostatin is an endogenous angiostatic factor identiﬁed
originally in conditioned media of murine hemangioen-
dothelioma cells [57, 58]. Many studies have shown that
the proteolytic release of endostatin from collagen XVIII
is mediated by proteases of many classes, such as cysteine
proteases, matrix metalloproteases, and aspartic proteases
[59, 60]. The potent antiangiogenic eﬀects of endostatin
are mediated via a combination of eﬀects on endothelial
cells, where endostatin inhibits cellular proliferation and
migration and stimulates apoptosis [61, 62]. The biological
eﬀects of endostatin are mainly attributed to its antagonism
of vascular endothelial growth factor (VEGF) signaling [63].
Angiogenesis has both beneﬁcial and deleterious eﬀects
in atherosclerosis. While increased angiogenesis in cardiac
tissue may be a favorable sign in the healing of the
ischemic tissues [64], progressive angiogenesis in a primary
atherosclerotic lesion could be a cause of plaque expansion
[65, 66]. There are several studies showing that exercise
induces a local angiogenic phenotype characterized by
overexpression of VEGF in skeletal muscle [67]a n dh e a r t
[64]. This phenomenon can prevent ischemia in these
tissues. Exercise can also exert beneﬁcial eﬀects against
atherosclerosis by increasing circulating endostatin, which
inhibits development of atherosclerotic plaque through
blocking angiogenesis in the plaque tissue [68]. Meanwhile,
Brixius et al. also reported that endurance activity improves
angiogenesis by reducing endostatin plasma levels[69]. Even
though the diﬀerent exercise protocols in these experiments
can explain these discrepant results, further studies are
needed to elucidate the precise mechanisms.
5.2. Arteriogenesis. Exercise training increases the diameter
of large arterioles, small arteries, and conduit arteries.
Another important aspect of exercise-induced changes in
capillarity is the onset and persistence of exercise-induced
arteriogenesis. The induction of arteriogenesis is an impor-
tant vascular adaptation [70], since arteriogenesis leads
to the formation of large conductance arteries capable of
compensating for the loss of function of occluded arteries.
Animal studies and clinical observations provide evidence
for a signiﬁcant correlation between regular physical exercise
and increased coronary artery lumen diameter [71, 72]. In
one study, an 8-week training programme increased the con-
tractile response to lowdoses of dobutaminein patients with
chronic coronary artery disease and having a left ventricular
ejection fraction below 40%. This implies that short-term
exercise training can improve quality of life by improving
left ventricular systolic function during mild to moderate
physical activity in patients with ischemic cardiomyopathy
[73]. Moreover, eight patients with coronary heart disease
and exertional angina pectoris successfully completed an 11–
15 week programme of endurance exercise conditioning.
Anginathresholdwasdeterminedbyuprightbicycleergome-
ter exercise and by atrial pacing. The product of heart rate
and arterial systolic blood pressure at the exercise angina
threshold was higher after conditioning, suggesting that
conditioning increased the maximum myocardial oxygen
supply during exercise [74].
6.CyclooxygenaseII and
Exercise-InducedCardioprotection
The phenomenonof ischemic preconditioningwhereby brief
episodes of sublethal ischemia renders the myocardium
resistant to subsequent ischemic stress occurs in two phases:
(i) an early phase that starts within a few minutes after
the initial ischemic stimulus, lasts for 2-3h, and is due
to adenosine and bradykinin release and (ii) a second
phase, which begins 12–24h later and lasts for 3-4 days
[75, 76]. This later phase of ischemic preconditioning is
caused by the simultaneous activation of multiple stress
responsive signaling pathways, including COX-2 and the
inducible form of nitric oxide synthase (iNOS), resulting
in the heart developing a phenotype that confers sustained
protectionagainst bothreversible(stunning)and irreversible
(infarction) myocardial I/R injury [76]. Similar to ischemic
stimuli, both short- (1–3 days) and long-term (weeks—
months) exercise protocols are equally eﬀectivein conferring
cardioprotection against I/R injury [77, 78].
Given the phenotypic similarities between ischemic and
exercise preconditioning, and since COX-2 and iNOS are
required to achieve the late phase of ischemic precondi-
tioning-induced cardioprotection against both I/R stunningCardiology Research and Practice 5
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and infarction [76, 79], it had been postulated that COX-
2 activity, and subsequent prostanoids production, may
also be essential for exercise-induced cardioprotection [80].
However, Nagy et al. reported that COX II inhibition did
not prevent exercise-induced cardioprotection against ven-
tricular arrhythmias after coronary occlusion in dogs [81].
Accordingly, studies by Quindry et al. [82, 83]r e v e a l e dt h a t
exercise does not elevate cardiac COX-2 activity. Therefore,
we conclude that diﬀerent mechanisms may be responsible




Another candidate mechanism explaining exercise-induced
cardioprotection is through a family of cardioprotective
protein collectively called endoplasmic reticulum (ER) stress
proteins. During a cardiac I/R insult, the ER helps cellular
homeostasis by maintaining intracellular calcium regulation
and protein folding [84]. Malfunction of the ER during an
I/R event can lead to both mitochondrial-dependent and
mitochondrial-independent cell death due to disruption of
calcium homeostasis and/or impaired protein folding [85].
The two most important ER stress proteins are Grp78 and
Grp94whichbelongtoHSPfamiliesandareoverexpressedin
cultured cardiomyocytes during oxidative stress and calcium
overload [86]. Martindale et al. suggested that the unfolded
protein response (UPR) is activated in the heart during I/R,
where formation of “Activation of Transcription Factor 6
(ATF6)” induces the expression of proteins such as Grp78
and Grp94, which in turn reduces I/R-induced necrosis and
apoptosis in the heart [87]. Since overexpression of these
ER stress proteins provide ER protection during an I/R
insult, it may be that these proteins contribute to exercise-
induced cardioprotection. However, studies by Murlasits et
al. demonstrate that at least short-term exercise training
doesnot elevateERstress proteins, and therefore, short-term




Nitric oxide plays a fundamental role in protecting the
heart against I/R injury. Speciﬁcally, it plays a critical
bifunctional role as a trigger and a mediator of late phase of
preconditioning. Increased production of NO by eNOS is an
important trigger in the late phase of ischemia and exercise-
induced preconditioning, and enhanced NO production by
iNOS is mandatory in the mediation of the antistunning
and antiinfarct actions of late preconditioning [89]. In other
words, the heart responds to ischemia by using two types
NOS isoforms in a harmonized manner; it uses preexisting
eNOS for a prompt burst of NO production, while at the
same time, there is upregulation of iNOS to switch to a
defensive phenotype by a sustained enhancement of NO
biosynthesis. The exact cardioprotective mechanisms of NO
during I/R is a subject of much debate; however, hypothe-
sized mechanisms include inhibition of calcium inﬂux into
myocytes [90], antagonism of β-adrenergic stimulation [91],
reduction in cardiac oxygen consumption [92, 93], and
actions on sarco KATP channels [94].
Although there are many studies on the cardioprotective
eﬀect of nitric oxide in I/R-induced preconditioning, there
are less investigations evaluating the protection aﬀorded by
nitric oxide in exercise-induced cardioprotection. Exercise
increases the expression and activity of eNOS, likely due6 Cardiology Research and Practice
to changes shear stress, which modulates the production
of NO [95–97]. Besides its vascular and metabolic eﬀects
(vasodilation, altered carbohydrate metabolism) [98], NO
possess a number of physiological properties which makes it
a cardioprotective molecule in the setting of myocardial I/R
injury. For example, NO reversibly inhibits mitochondrial
respiration [99]a n da p o p t o s i s[ 100]. This eﬀect results in
a reduction in mitochondrial-induced cardiac injury in the
failing human heart. Babai et al. showed that even a single
period of exercise aﬀords delayed protection against I/R-
induced ventricular tachycardia and other ischemic changes
that are mediated by NO [101]. Further evidence for a
central role of eNOS in exercise physiology comes from
experiments with eNOS deﬁcient mice (eNOS−/−). Running
capacity in these animals is 50%–60% less than age-matched
wild-type mice [102, 103]. de Waard et al. found that the
beneﬁcial eﬀects of exercise after MI on LV remodeling and
dysfunction depends critically on endogenous eNOS. They
observed that the lack of one eNOS allele is suﬃcient to
negate all beneﬁcial eﬀects of exercise, strongly suggesting
that the beneﬁcial eﬀects of exercise depends on full eNOS
expression [104] .T a y l o re ta l .i na ni nv i t r os e t t i n gs h o w e d
thatexercise canrenderacardioprotectivephenotypeagainst
I/R insult even in the presence of blockade of all NOS
isoforms with L-NAME, leading them to conclude that
acute exercise-induced preconditioning is not mediated by
NOS (or either increases in HSP 72 or other antioxidant
enzymes) [105]. These discrepant ﬁndings can be accounted
for by considering the role of nitrite and nitrates in the
physiology of the cardiovascular system. For example, it
h a sb e e ns h o w nt h a tn i t r i t e( a n dn i t r a t e s )a c t sa sas t o r a g e
reservoir on NO so that under pathological conditions such
as ischemia and hypoxia, nitrite can readily be reduced to
NO[106, 107]. The beneﬁcial eﬀectof nitrite therapy (which
generates NO-independent of eNOS) has been shown in
animal models of cardiac I/R injury [108, 109]. Nitrite levels
are increased following exercise in both rodents and humans
[110,111].Sincenitriteaccumulatedintheheartcanprovide
cardioprotection during an ischemic event by being reduced
to NO, it is likely that NO produced from endothelial cells
during exercise can be oxidized to nitrite, transported in
the plasma to then aﬀect the heart or vasculature. In the
case of myocardial ischemia, nitrite can be reduced back to
NOand exert cardioprotectionin an NO-dependentmanner
[112]. This hypothesis potentially could be applied to all
the experiments in which exercise-induced cardioprotection
was not abolished in the presence of an inhibitor of NOS
[105, 113]. To add to the importance of NO in exercise
physiology is its ability to activate KATP channels through
cGMP-PKG signaling [114, 115] and to increase expression
of HSP70 [116] during exercise.
9.RoleofSarcoand Mito KATP Channels in
Exercise-InducedCardioprotection
Several lines of evidence indicate that sarco KATP channels
are involved in cardiac I/R injury. The KATP channel was
ﬁrst described in 1983 and was named for the inhibitory
eﬀect of cytosolic ATP on potassium channel opening [117].
During ischemia, heart cells become energy depleted, which
leads to increased anaerobic glycolysis to compensate for
ATP depletion. The resulting acidosis increases the inﬂux
of Na via the Na/H exchanger and inhibits the ATP-
dependent sarcolemmal Na/K ATPase to augment the initial
accumulation of Na [118]. The high intracellular Na concen-
tration prompts the Na/Ca exchanger to work in the reverse
mode, producing cytosolic and mitochondrial Ca overload
[119]. Upon reperfusion, a burst of ROS is generated by
mitochondria, while intracellular Na overload continues as a
result of the impaired function of Na/K ATPase (Figure 3(a)
and 3(b)).
TheNa/KATPasepumpisatransmembraneheterodimer
protein composed of α and β subunits. The cytoplasmic
domain of α subunit interacts with ankyrin, a protein that
connects the Na/K ATPase to the fodrin-based membrane
skeleton [120]. Ankyrin and fodrin are major components
of the membrane cytoskeleton in a variety of nonerythroid
cells [121]. They are also substrates of calpains, a group
of nonlysosomal Ca-dependent proteases. Previous studies
demonstrated activation of calpain leading to the degrada-
tion of both ankyrin and fodrin during reperfusion [120].
The resulting increased intracellular concentrations of Na
and Ca, along with low ATP levels, lead to additional
mitochondrial ROS production and to activation of other
proteases, which result in decreased sarcoplasmic reticulum
calcium transport and dysfunctional contractile proteins
[122]. Increased cytosolic Ca levels also contribute to the
opening of the mitochondrial permeability transition pore
(mPTP), resulting in a loss of mitochondrial membrane
potentialandreducedATPproduction[123].Thedecr easein
ATP production leads to opening of KATP channels on both
the sarcolemmal and mitochondria. It was Noma [117]w h o
initially hypothesized that opening of sarco KATP channels
induced by hypoxia, ischemia, or pharmacological KATP
openers shortens the cardiac action potential duration by
accelerating phase III repolarization. An enhanced phase 3
repolarization would inhibit Ca entry into the cell via L-
type channels and prevent Ca overload. Furthermore, the
slowing of depolarization would also reduce Ca entry and
slow or prevent the reversal of the Na/Ca exchanger. These
actions would increase cell viability via a reduction in Ca
overload during ischemia and early reperfusion. Additional
evidence supporting the protective role of sarco KATP chan-
nels was provided by other investigators [123–127]. Exercise
training increases the expression of cardiac sarco KATP,
and moreover, pharmacological blockage of these channels
impairs cardioprotection[128]. The sex-speciﬁc and exercise
acquired resistance to myocardial I/R injury is dependent
on sarco KATP activity during ischemia [129]. Interestingly,
female animals have higher sarco ATP sensitive potassium
channel expression [130] and estrogen can upregulate the
expression of these channels [131]. Administration of HMR-
1098, a sarcolemmal KATP channel blocker, abolished the
sex-dependent diﬀerences in infarct size [132, 133]. It is
likely that the smaller infarct size in female hearts reported
in some studies may be related to an increase activity
of protein kinases B (also known as Akt) and C [134],
which cause increased recruitment of KATP in myocyteCardiology Research and Practice 7
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Figure 3: (a, b) Pathophysiologicalconsequences of (a) ischemia and (b) reperfusion. (mPTP, mitochondrial permeability transition pore).
sarcolemma. Inhibition of these kinases before ischemia
expanded infarct size in female (butnot male) hearts. Recent
studies suggest that inhibition of KATP channels and of
PKC are not additive, suggesting that activation of PKC
and KATP channels are diﬀerent components of the same
signaling pathway [135]. Activation of PKC by adenosine
downregulatesKATP channels [136].Itispossiblethatontype
of PKC is active following exercise which upregulates KATP
channels, while the activation of adenosine receptors activate
another type of PKC which downregulates these channels
[137]. The fact that PKC mediated activation of sarco KATP
channels is sex dependentsuggests thepresence of regulatory
component(s) that either may not be present, or regulated
in a diﬀerent manner, in males. These ﬁndings show the
complexity of signaling pathway(s) that regulate the density
and function of sarco KATP channels in preconditioned and
nonpreconditioned hearts in a gender-dependent manner. A
full understanding of the mechanisms underlying regulation
of sarco KATP is an exciting task for the future that certainly
will haveasigniﬁcantimpactontherapeuticstrategies forthe
prevention and treatment of cardiovascular diseases.
Several lines of evidence conﬁrm the role of mitochon-
drial K channels in protection against I/R injury [138–
140]. Prostacyclin analogs protect cardiac myocytes from
oxidative stress mainly via activation of type 3 of PE2
receptors during I/R injury. Activation of these receptors
primes the opening of mitochondrial KATP channels [141].
However, there is some controversy about the role of mito
kATP channels in exercise preconditioning of the heart. For
example, Domenech et al. reported that the early eﬀect of
exercise preconditioning of the heart is mediated through
mito kATP channels [142], while Brown et al. reported
that mito kATP channels are not an essential mediator of
exercise-induced protection against I/R-induced myocardial
infarction [128]. It has also been recently suggested that
mito KATP channels provide antiarrhythmic eﬀects as part of
exercise-induced cardioprotection against I/R injury [143].
It should be mentioned that the molecular characteristics of8 Cardiology Research and Practice
mito kATP channels remains elusive. Additional research is
needed before deﬁnitive conclusions can be drawn.
10.ExerciseandCardiacMitochondria
There is an important role for mitochondria in I/R injury.
Exercise training results in cardiac mitochondrial adapta-
tions that result in decreased ROS production, increas-
ing their ability to tolerate high calcium levels. Lifelong
voluntary wheel running reduced cardiac subsarcolemmal
and interﬁbrillar mitochondrial hydrogen peroxide produc-
tion in rats [144]. Similarly, endurance exercise reduces
ROS production in myocardial mitochondria, resulting in
less calcium inﬂux upon reperfusion [145]. Reduction in
ROS production could be related to decreased superoxide
production or increased mitochondrial antioxidant enzyme
activity. A study by Judge et al. [144] indicated that MnSOD
activity was signiﬁcantly lowered in subsarcolemmal and
interﬁbrillar mitochondria, leading to the suggestion this
may reﬂect a reductioninmitochondrial superoxideproduc-
tion. However, this issue is currently a matter ofconsiderable
debate.
Mitochondria of exercised animals are able to tolerate
higher levels of calcium. Mitochondria isolated from hearts
of exercised animals are more resistant to calcium-induced
mPTPopening[146].Furthermore,exercisetraining induces
a mitochondrial phenotype that is protective against apop-
totic stimuli [147]. These changes include increases in the
protein levels of primary antioxidant enzymes in both
subsarcolemmal and interﬁbrillar mitochondria, attenuation
of ROS-induced cytochrome c release, reduced maximal
rates of mPTP opening (Vmax), and prolonged time to V(max)
in both subsarcolemmal and interﬁbrillar mitochondria,
and increased levels of antiapoptotic proteins including the
apoptosis repressor with a caspase recruitment domain.
These results are consistent with the concept that exercise-
induced mitochondrial adaptations contribute to exercise-
induced cardioprotection and are compatible with our study
on the eﬀect of exercise on renal mitochondria in diabetic
mice [148].
Monoamine oxidase enzymes are located on the outer
mitochondrial membrane and are divided into 2 major
forms A and B based on genetic criteria, substrate speciﬁcity,
and inhibition by synthetic compounds. The degradation of
biogenicamines (serotonin and catecholamines) isthemajor
physiological function of these enzymes [149]a n dM A O -
A, which is the predominant isoforms expressed in cardiac
ventricle, also represents an important source of ROS in the
heart [150]. Moreover, its ability to produce ROS increases
with aging and its expression is upregulated during cardiac
hypertrophy and failure [151]. A study by Bianchi et al.
investigating the potential role of ROS generated by MAO-
A during 5-HT degradation in cardiomyocyte death and its
role in post-I/R damage showed that MAO is responsible
for receptor-independent apoptotic eﬀects of 5-HT in car-
diomyocytes and post-ischemic myocardial injury. They also
provided evidence that H2O2 production by MAO-A plays
a critical role in post I/R events leading to cardiac damage
[152]. Another in vivo study using MAO-A knockout mice
showed that these animals were protected from I/R-induced
cardiac damage and this protection was related to signif-
icantly lower ROS generation following I/R injury [153].
Interestingly, Kavazis et al. showed that MAO-A protein
levelswere signiﬁcantly reducedinbothsubsarcolemmal and
intermyoﬁbrillar mitochondria following exercise training
[154]. They proposed that down regulation of MAO-A
protein expression following endurance exercise is one of the
mechanisms for exercise-induced cardioprotection.
Other eﬀects of exercise on cardiac mitochondria relates
to proteins involved in bioenergetics. This regulation may
help to meet the increased energy demands during exercise
or improved cardiac function during resting conditions.
Thus, repeated bouts of exercise increase the mitochondrial
levels of several enzymes such as acyl-CoA dehydroge-
nase, hydroxyacyl-CoA dehydrogenase, and δ(3,5)- δ(2,4)-
dienoyl-CoA isomerase that are involved in the β-oxidation
of fatty acids [51]( Figure 4).
11.Exerciseand Autophagy
Autophagy or autophagocytosis is a universal, dynamic
process that takes place in all eukaryotic cells and helps
to maintain a balance between the synthesis, degradation
and subsequent recycling of cellular products. This process
consists ofthree phases: (a)formation and engulfment ofthe
target by a double-membrane vesicle called an autophago-
some, (b) delivery of autophagosomes to lysosomes, and (c)
degradation of the autophagosomes and its content by lyso-
somal proteases [155]. Autophagy plays an important role
in the basal turnover of intracellular proteins and organelles
and production of amino acids in nutrient emergency.
These functions guarantee rejuvenation and adaptation to
changing or adverse conditions and even underlie dynamic




of autophagy lead to breakdown of nonvital components
and the release of nutrients, ensuring that vital processes can
continue. Mutant yeast cells that have a reduced autophagic
capability rapidly perish in nutrition deﬁcient conditions
[156]. In brief, autophagy is a mechanism by which cells, in
timesofnutrient shortage,candegradeproteinformetabolic
needs and simultaneously eliminate unwanted, damaged,
or redundant cell membranes and organelles including
mitochondria, endoplasmic reticulum, and peroxisomes; in
this regard, autophagy contrasts with the accumulation of
damaged cells that naturally occurs during the process of
aging. Decreased autophagy can promote the development
of cancer [157] and neurodegenerative conditions including
Alzheimer’s [158] and Parkinson’s disease [159]. In the
heart, autophagy can protect against apoptosis activated
by ischemic injury [160], and its chronic perturbation is
causative in genetic forms of heart disease [161]. Conversely,
autophagy can also be a form of programmed cell death
linked to, but distinct from, apoptosis [162, 163].
Theinductiveeﬀectofcaloricrestrictionandsuppression
of autophagy by excessive caloric intake can also play rolesCardiology Research and Practice 9
Less mPTP opening and reduced
cytochrome C release
Decreased apoptosis and remodeling
Decreased MAO-A activity which leads to
less ROS production
Regulation of protein/enzymes involved in
energy production
Mitochondria
↓ ROS production and less Ca inﬂux during
reperfusion
Figure 4: selected exercise-induced mitochondrial change in cardiac muscles. (Mitochondrial permeability transition pore, mPTP).
in the metabolic syndrome, type II diabetes, and aging
[164, 165].
We conclude that exercise mediates its cardiopro-
tective eﬀects, in part, by induction and up regula-
tion of autophagy [166–169]. Exercise-induced autophagic
responses are diminished in people with the metabolic
syndrome, type II diabetes, or sedentary life styles. Agents
known to induce pharmacological conditioning, such as
adenosine and diazoxide, are also inducers of autophagy
[170]. Autophagy is upregulated in the chronically ischemic
myocardium, where there is an inverse relationship with
the extent of apoptosis [171]. Myocardial protection elicited
by adaptation to ischemia is mediated at least in part via
upregulation of autophagy [160, 172].
12.Summary
There is ﬁrm evidence from observational and randomized
trials that regular exercise contributes to the primary, sec-
ondary and tertiary prevention of cardiovascular and several
other lifestyle-dependent diseases and that regular exercise
is associated with a reduced risk of premature death. The
detailed molecular mechanisms behind this favorable eﬀect
remain unknown and continue to be actively investigated at
various levels although there is signiﬁcant evidence favoring
redox homeostasis during cardioprotection. For the sake
of clarity, we propose to divide the potential mechanisms
into two major categories: those mechanisms that mainly
decrease ROS production and other mechanisms that are
more eﬀective in repair and housekeeping (Table 3). These
molecular adaptations lead to better physiological function
and enhanced resistance to oxidative stress.
Among the proposed mechanisms for exercise-induced
cardioprotection, changes in mitochondrial function and
sarco KATP channel regulation play more signiﬁcant roles.
Indeed, mitochondria are important determinants of sur-
vival in cardiac myocytes exposed to I/R [173, 174]. There-
fore, its adaptations during exercise can have a greater
Table 3: Proposed mechanisms in exercise-induced cardioprotec-
tion.











(iii) ↑ER stress proteins
impact oncardiacmuscles.Just asimportant istheprotective
role of NO, which in addition to matching blood ﬂow to
metabolic demands also has antiatherosclerotic properties
(inhibits inﬂammatory cells and platelets from adhering
to the vascular walls) and can increase the expression of
HSP70 and activate KATP channels. It seems likely that other
unknown cardioprotective mediators also exist and may
contribute to exercise preconditioning, stressing the need
for additional research to determine how the integration
of the diﬀerent pathways can lead to cardioprotection.
Another important consideration is to better understand the
impact of diﬀerent exercise protocols (type, duration, and
intensity) and gender diﬀerences on the time course and
extent of exercise-induced cardioprotection, as this will have
implications for both ongoing preventative health care as
well as for developing therapeutic strategies, for example, in
the management of some patients with cardiac diseases.
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